@Pseudoname1 MM always points to some negotiation so I don't think you could hang your hat on that being the case.
She stated that BIT was sharing and talking with other participants in the biotech sector - that is a long way from being a negotiation by definition.
I do agree that BIT should be investigating the general antiviral sector as a potential future development - but that would require a new trial series directed at that need - which is real.
That also will require considerable funds which BIT does not currently have.
Glad your little daughter is doing well. That would have been traumatic.
Apologies - reply tab not working.
Ann: Application for quotation of securities - BIT, page-20
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $25.26M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.8¢ | 2.6¢ | $3.254K | 120.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 232048 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 264517 | 2 |
View Market Depth
| Last trade - 15.57pm 28/08/2024 (20 minute delay) ? |
| BIT (ASX) Chart |